France · Delayed Price · Currency is EUR BIO-UV Group Statistics
Total Valuation
BIO-UV Group has a market cap or net worth of EUR 14.64 million. The enterprise value is 25.33 million.
| Market Cap | 14.64M |
| Enterprise Value | 25.33M |
Important Dates
The next estimated earnings date is Friday, October 2, 2026.
| Earnings Date | Oct 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BIO-UV Group has 13.55 million shares outstanding. The number of shares has increased by 17.07% in one year.
| Current Share Class | 13.55M |
| Shares Outstanding | 13.55M |
| Shares Change (YoY) | +17.07% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.18% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 81.38.
| PE Ratio | 81.38 |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | 8.41 |
| P/OCF Ratio | 4.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.03, with an EV/FCF ratio of 14.56.
| EV / Earnings | 134.84 |
| EV / Sales | 0.68 |
| EV / EBITDA | 18.03 |
| EV / EBIT | 36.28 |
| EV / FCF | 14.56 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.45.
| Current Ratio | 2.21 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 13.13 |
| Debt / FCF | 10.60 |
| Interest Coverage | 1.01 |
Financial Efficiency
Return on equity (ROE) is 0.46% and return on invested capital (ROIC) is 1.35%.
| Return on Equity (ROE) | 0.46% |
| Return on Assets (ROA) | 0.60% |
| Return on Invested Capital (ROIC) | 1.35% |
| Return on Capital Employed (ROCE) | 1.20% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | 260,892 |
| Profits Per Employee | 1,314 |
| Employee Count | 143 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.23 |
Taxes
| Income Tax | -81,980 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.92% in the last 52 weeks. The beta is 0.28, so BIO-UV Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -32.92% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 18.73 |
| Average Volume (20 Days) | 15,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIO-UV Group had revenue of EUR 37.31 million and earned 187,832 in profits. Earnings per share was 0.01.
| Revenue | 37.31M |
| Gross Profit | 23.34M |
| Operating Income | 698,057 |
| Pretax Income | 105,852 |
| Net Income | 187,832 |
| EBITDA | 1.40M |
| EBIT | 698,057 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 7.75 million in cash and 18.44 million in debt, with a net cash position of -10.69 million or -0.79 per share.
| Cash & Cash Equivalents | 7.75M |
| Total Debt | 18.44M |
| Net Cash | -10.69M |
| Net Cash Per Share | -0.79 |
| Equity (Book Value) | 41.16M |
| Book Value Per Share | 3.04 |
| Working Capital | 16.98M |
Cash Flow
In the last 12 months, operating cash flow was 3.31 million and capital expenditures -1.57 million, giving a free cash flow of 1.74 million.
| Operating Cash Flow | 3.31M |
| Capital Expenditures | -1.57M |
| Depreciation & Amortization | 706,458 |
| Net Borrowing | -2.66M |
| Free Cash Flow | 1.74M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 62.57%, with operating and profit margins of 1.87% and 0.50%.
| Gross Margin | 62.57% |
| Operating Margin | 1.87% |
| Pretax Margin | 0.28% |
| Profit Margin | 0.50% |
| EBITDA Margin | 3.76% |
| EBIT Margin | 1.87% |
| FCF Margin | 4.66% |
Dividends & Yields
BIO-UV Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.07% |
| Shareholder Yield | -17.07% |
| Earnings Yield | 1.28% |
| FCF Yield | 11.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIO-UV Group has an Altman Z-Score of 1.26 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 5 |